CDX2 and tuberous sclerosis: To determine the transcriptional state that describes undifferentiated, bona fide TSCs and to monitor transcriptional changes during early TSC differentiation, we used genetic tools to manipulate Eomes and Cdx2 expression in TSC cultures followed by genome wide transcriptional profiling.